Combination therapies for COVID‐19: An overview of the clinical trials landscape-Reference-Cited by-同舟云学术

Combination therapies for COVID‐19: An overview of the clinical trials landscape

Published:2021-10-17 Issue: Volume: Page:
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Akinbolade Sola¹^ORCID,Coughlan Diarmuid¹,Fairbairn Ross¹,McConkey Glenn²,Powell Helen³,Ogunbayo Dapo¹,Craig Dawn¹

Affiliation:

1. National Institute for Health Research (NIHR) Innovation Observatory, Population Health Sciences Institute, Faculty of Medical Sciences Newcastle University Newcastle UK

2. Medical Research Council (MRC) – UK Research and Innovation (UKRI)/University of Leeds Leeds UK

3. National Institute for Health and Care Excellence (NICE) Manchester UK

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.15089

Reference56 articles.

1. WHO declares COVID‐19 a pandemic;Cucinotta D;Acta Bio Medica: Atenei Parmensis,2020

2. WillanJ KingAJ JefferyK BienzN.Challenges for NHS hospitals during covid‐19 epidemic.2020;368:m1117.

3. Comprehensive analysis of drugs to treat SARS‑CoV‑2 infection: Mechanistic insights into current COVID‑19 therapies (Review)

4. EggletonJS NagalliS.Highly Active Antiretroviral Therapy (HAART). Treasure Island FL: StatPearls Publishing;2020.

5. The end of AIDS: HIV infection as a chronic disease

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel multitargeted self-assembling peptide-siRNA complex for simultaneous inhibition of SARS-CoV-2-host cell interaction and replication;Molecular Therapy - Nucleic Acids;2024-09

2. Early combination of sotrovimab with nirmatrelvir/ritonavir or remdesivir is associated with low rate of persisting SARS CoV-2 infection in immunocompromised outpatients with mild-to-moderate COVID-19: a prospective single center study;2024-07-15

3. COVID-19 therapeutics;Clinical Microbiology Reviews;2024-06-13

4. Spectroscopic characterization and quantum chemical calculations on Favipiravir-Guanine biomolecular complex;Spectroscopy Letters;2024-05-16

5. Pharmacokinetic considerations for enhancing drug repurposing opportunities of anthelmintics: Niclosamide as a case study;Biomedicine & Pharmacotherapy;2024-04